PT1299095E - Composicao anestesica aquosa limpida - Google Patents

Composicao anestesica aquosa limpida

Info

Publication number
PT1299095E
PT1299095E PT00991825T PT00991825T PT1299095E PT 1299095 E PT1299095 E PT 1299095E PT 00991825 T PT00991825 T PT 00991825T PT 00991825 T PT00991825 T PT 00991825T PT 1299095 E PT1299095 E PT 1299095E
Authority
PT
Portugal
Prior art keywords
propofol
aqueous
compositions
hydroxypropyl
beta
Prior art date
Application number
PT00991825T
Other languages
English (en)
Portuguese (pt)
Inventor
Srikanth Pai
Sangeeta Rivankar
Shilpa Kocharekar
Original Assignee
Bharat Serums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd
Publication of PT1299095E publication Critical patent/PT1299095E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT00991825T 2000-06-21 2000-12-14 Composicao anestesica aquosa limpida PT1299095E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN573MU2000 IN187686B (h) 2000-06-21 2000-06-21

Publications (1)

Publication Number Publication Date
PT1299095E true PT1299095E (pt) 2004-10-29

Family

ID=11097257

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00991825T PT1299095E (pt) 2000-06-21 2000-12-14 Composicao anestesica aquosa limpida

Country Status (26)

Country Link
US (1) US7138387B2 (h)
EP (1) EP1299095B1 (h)
JP (1) JP4907833B2 (h)
KR (1) KR100810066B1 (h)
CN (1) CN1254237C (h)
AP (1) AP2002002674A0 (h)
AT (1) ATE267592T1 (h)
AU (2) AU3597201A (h)
BG (1) BG107463A (h)
BR (1) BR0017268A (h)
CA (1) CA2414064C (h)
DE (1) DE60011149T2 (h)
DK (1) DK1299095T3 (h)
EA (1) EA005589B1 (h)
ES (1) ES2222271T3 (h)
HU (1) HUP0301646A3 (h)
IL (1) IL153387A0 (h)
IN (1) IN187686B (h)
MX (1) MXPA02012611A (h)
NO (1) NO20025999D0 (h)
NZ (1) NZ523643A (h)
PL (1) PL359624A1 (h)
PT (1) PT1299095E (h)
WO (1) WO2001097796A1 (h)
YU (1) YU2703A (h)
ZA (1) ZA200300336B (h)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN188917B (h) * 2000-12-07 2002-11-23 Bharat Surums & Vaccines Ltd
US7034013B2 (en) 2001-03-20 2006-04-25 Cydex, Inc. Formulations containing propofol and a sulfoalkyl ether cyclodextrin
CN1329036C (zh) * 2001-12-28 2007-08-01 Mgigp公司 普鲁泊福水溶性前药的以水为基质的药物制剂
JP2005522422A (ja) * 2002-02-01 2005-07-28 シモダ、バイオテック(プロプライエタリー)リミテッド 医薬組成物
CA2494297C (en) 2002-07-29 2011-10-18 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
US7550155B2 (en) 2002-07-29 2009-06-23 Transform Pharmaceuticals Inc. Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
EP1585548B1 (en) * 2002-12-09 2018-06-27 Abraxis BioScience, LLC Compositions and methods of delivery of pharmacological agents
KR20060130646A (ko) * 2004-01-14 2006-12-19 가부시키가이샤 오츠까 세이야꾸 고죠 프로포폴 함유 지방 유제
WO2006030450A2 (en) * 2004-09-13 2006-03-23 Bharat Serums & Vaccines Ltd. Stable emulsion compositions for intravenous administration having antimicrobial preservative efficacy
CA2618799C (en) * 2005-08-12 2013-06-04 Bharat Serums & Vaccines Ltd. Aqueous anaesthetic compositions comprising propofol
WO2007128866A2 (en) * 2006-05-09 2007-11-15 Novobion Oy Novel chemical compositions
EP2269116A4 (en) * 2008-03-11 2011-09-07 3M Innovative Properties Co PHOTOGRAPHIC MASKS HAVING PROTECTIVE LAYER
WO2010148288A2 (en) * 2009-06-19 2010-12-23 Lyotropic Therapeutics, Inc. Pharmaceutical formulations with low aqueous levels of free unbound drug
EP2456823A4 (en) 2009-07-21 2012-12-26 3M Innovative Properties Co CURABLE COMPOSITION, METHOD FOR COATING A PHOTO TOOL, AND COATED PHOTO TOOL
CN102549042B (zh) 2009-09-16 2015-01-28 3M创新有限公司 氟化涂料和用其制作的底片
WO2011034847A1 (en) 2009-09-16 2011-03-24 3M Innovative Properties Company Fluorinated coating and phototools made therewith
US8268067B2 (en) * 2009-10-06 2012-09-18 3M Innovative Properties Company Perfluoropolyether coating composition for hard surfaces
EP2345427A1 (de) * 2010-01-14 2011-07-20 SapioTec GmbH Flurankomplex
EP2484350B1 (de) * 2011-02-04 2016-04-20 Roewer, Norbert, Univ.-Prof. Dr. med. Pharmazeutische Zubereitung, enthaltend einen Komplex eines Propofolsalzes mit einem Cyclodextrin
IN2014KN01341A (h) 2011-11-29 2015-10-16 Jurox Pty Ltd
AU2013273764B2 (en) * 2011-11-29 2016-05-05 Zoetis Services Llc Pharmaceutical compositions
CN103263404B (zh) * 2012-04-28 2017-12-01 中国人民解放军军事医学科学院放射与辐射医学研究所 一种复合麻醉药物
AU2013305767B2 (en) 2012-08-21 2018-05-24 Sage Therapeutics, Inc. Methods of treating epilepsy or status epilepticus
US10646439B2 (en) * 2016-01-29 2020-05-12 Cuda Anesthetics, Llc Aqueous pharmaceutical formulation comprising propofol
FR3117337B1 (fr) 2020-12-10 2023-04-28 Centre Hospitalier Univ De Lille Composition pharmaceutique contenant du propofol, une cyclodextrine ou un dérivé de cyclodextrine et un sel pharmaceuticalement acceptable

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA962214B (en) * 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition

Also Published As

Publication number Publication date
WO2001097796A1 (en) 2001-12-27
EA005589B1 (ru) 2005-04-28
US7138387B2 (en) 2006-11-21
IN187686B (h) 2002-06-08
NZ523643A (en) 2004-05-28
CN1454085A (zh) 2003-11-05
DE60011149T2 (de) 2005-07-07
NO20025999L (no) 2002-12-13
CA2414064A1 (en) 2001-12-27
CA2414064C (en) 2013-01-08
EP1299095B1 (en) 2004-05-26
EA200300047A1 (ru) 2003-06-26
US20040014718A1 (en) 2004-01-22
KR100810066B1 (ko) 2008-03-05
HUP0301646A2 (hu) 2003-09-29
ZA200300336B (en) 2004-04-08
BG107463A (en) 2003-11-28
DE60011149D1 (de) 2004-07-01
YU2703A (sh) 2006-03-03
AP2002002674A0 (en) 2002-12-31
EP1299095A1 (en) 2003-04-09
KR20030023875A (ko) 2003-03-20
CN1254237C (zh) 2006-05-03
BR0017268A (pt) 2003-05-27
DK1299095T3 (da) 2004-10-11
HUP0301646A3 (en) 2005-06-28
AU3597201A (en) 2002-01-02
JP2003535893A (ja) 2003-12-02
NO20025999D0 (no) 2002-12-13
ES2222271T3 (es) 2005-02-01
JP4907833B2 (ja) 2012-04-04
ATE267592T1 (de) 2004-06-15
IL153387A0 (en) 2003-07-06
AU2001235972B2 (en) 2005-07-21
MXPA02012611A (es) 2004-07-30
PL359624A1 (en) 2004-08-23

Similar Documents

Publication Publication Date Title
PT1299095E (pt) Composicao anestesica aquosa limpida
UY26635A1 (es) Métodos sinérgicos y composiciones para el tratamiento del cáncer
BR0111206A (pt) Derivados de arilmetilamina para uso como inibidores de triptase
AR037517A1 (es) Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
AR053162A1 (es) Compuesto 5 - oxo - pirrolidin sustituido, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento del glaucoma.
ATE409048T1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
SE0001899D0 (sv) New compounds
EP1819227A4 (en) PHARMACEUTICAL FORMULATIONS OF DECITABIN
ECSP066312A (es) Derivados piridilo y su uso como agentes terapéuticos
DE60133555D1 (de) Verbindungen und gemische zur verabreichung eines aktiven agens
AR046651A1 (es) Composicion purgante colonica con agente aglutinante soluble
UA91512C2 (ru) Коньюгати олигомеров инсулина, их композиция (варианты) и применение
AR055095A1 (es) Nuevos inhibidores macrociclicos de la replicacion del virus de la hepatitis c
PT1390039E (pt) Utilizacao de compostos estrogenicos para aumentar a libido nas mulheres
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
HUT75513A (en) Taxane class derivative based pharmaceutical compositions and their preparation
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente
AR048336A1 (es) Hidrocloruro de (4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il)-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
BRPI0409380A (pt) composições farmacêuticas
UA93365C2 (ru) Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
ES2105923B1 (es) Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv).
AR028987A1 (es) Compuesto derivado de ciclopentapiridin-cetona, composicion farmaceutica que lo contiene y su uso en la fabricacion de un medicamento util para tratar una enfermedad
BR0109617A (pt) Composição farmacêutica, oligossacarìdeo, processo de preparação de oligossacarìdeos, e, utilização de oligossacarìdeos
ATE261732T1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl